Article
Season 2, Episode 16: Breaking Barriers with Jacob Becraft
Join Michael Pietrack on the Pharmaverse Podcast as he interviews Jake Becraft, CEO & Co-founder of Strand Therapeutics! Discover how Jake is transforming cancer treatment with programmable mRNA therapies.
Hear about his journey from a small town in Illinois to MIT, how jiu-jitsu shaped his leadership, and the lessons of team-building, failure, and innovation. Learn about Strand’s breakthroughs, including the game-changing abscopal response, and the mindset needed to challenge scientific dogma.
Related Topics
You May Also Like
Article
Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects
Article
Outcome measures for oncology alternative payment models: practical considerations and recommendations
Article
Leveraging existing data to contextualize phase II clinical trial findings in oncology
Article
Proportion of Patients in Phase I Oncology Trials Receiving Treatments That Are Ultimately Approved
Article